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Signal transduction pathways converge upon sequence-specific DNA binding factors to reprogram
gene expression. Transcription factors, in turn, team up with chromatin modifying activities.
However, chromatin is not simply an endpoint for signaling pathways. Histone modifications relay
signals to other proteins to triggermore immediate responses than can be achieved through altered
gene transcription, which might be especially important to time-urgent processes such as the
execution of cell-cycle check points, chromosome segregation, or exit from mitosis. In addition,
histone-modifying enzymes often havemultiple nonhistone substrates, and coordination of activity
toward different targets might direct signals both to and from chromatin.Introduction
Signal transduction classically involves coordinated cascades
of protein phosphorylation or dephosphorylation, which in turn
alter protein conformation, protein-protein interactions, subcel-
lular protein locations, or protein stability. In many cases, these
pathways begin at the cell surface and extend into the nucleus,
where they alter the interactions of transcription factors and
chromatin-modifying enzymes with the chromatin template. In
some cases, signaling promotes such interactions, whereas in
others, factors are ejected from chromatin in response to
incoming signals. Several such pathways have been defined
that control developmental fate decisions or response to physi-
ological or environmental changes (for examples, see Fisher and
Fisher, 2011; Long, 2012; Valenta et al., 2012). In these cases,
the ultimate endpoint of the signal is often considered to be
a modification of chromatin structure to modulate DNA accessi-
bility to control gene expression.
The architecture of chromatin can be altered by a variety
of mechanisms, including posttranslational modification of
histones, alterations in nucleosome locations, and exchange of
canonical histones for histone variants. Histone modifications
have at least three nonmutually exclusive effects on chromatin
packing (Butler et al., 2012; Suganuma and Workman, 2011).
First, modifications such as acetylation or phosphorylation can
alter DNA:histone and histone:histone interactions. Second,
histone acetylation, methylation, and ubiquitylation can create
binding sites for specific protein motifs, thereby directly
promoting or inhibiting interactions of regulatory factors with
chromatin (Smith and Shilatifard, 2010; Yun et al., 2011). Bromo-
domains, for example, promote interactions with acetyl-lysines
within histones. PHD domains, Tudor domains, and chromo
domains can selectively bind particular methylated lysines
(Kme). At least one Tudor domain (TDRD3) serves as a readerfor methylarginine (Rme) residues (Yang et al., 2010). In contrast,
other domains, such as the PhD finger in BHC80 (Lan et al.,
2007), are repelled by lysine methylation. Such regulation is
enhanced by combining domains to createmultivalent ‘‘readers’’
of histone modification patterns (Ruthenburg et al., 2007). The
combination of PhD and bromodomains in the TRIM24 protein,
for example, creates a motif that specifically recognizes histone
H3K23 acetylation in the absence of H3K4 methylation (Tsai
et al., 2010). Third, histone modifications also affect the chro-
matin landscape by influencing the occurrence of other modifi-
cations at nearby sites (Lee et al., 2010). Methylation of H3R2,
for example, inhibits methylation of H3K4, but not vice versa
(Hyllus et al., 2007; Iberg et al., 2008). Such modification ‘‘cross-
talk’’ can result either from direct effects of a pre-existing modi-
fication on the ability of a second histone-modifying enzyme to
recognize its substrate site or from indirect effects on substrate
recognition through the recruitment of ‘‘reader proteins’’ that
mask nearby modification sites. Binding of the chromodomain
in the HP1 protein to H3K9me blocks subsequent phosphoryla-
tion of S10 by Aurora kinases, for example (Fischle et al., 2003).
The Power of Crosstalk
Histone modification crosstalk can also occur in trans between
sites on two different histones. The most studied example of
such crosstalk is the requirement of H2B monoubiquitylation
for methylation of H3K4 (Shilatifard, 2006). In yeast, the Bre1
E3 ligase ubiquitylates H2BK123 and works together with the
Paf1 complex to recruit the Set1 H3K4 methyltransferase
complex, often referred to as COMPASS, to gene promoters
(Lee et al., 2010). Bre1-mediated H2B ubiquitylation also
stimulates H3K79 methylation by the Dot1 methyltransferase
(Nakanishi et al., 2009; Ng et al., 2002). Each of these histone
modifications is widely associated with actively transcribedCell 152, February 14, 2013 ª2013 Elsevier Inc. 685
Figure 1. Regulation of RelA/NF-kB by a Phosphomethyl Switch and
in Response to DNA Damage
(A) Methylation of RelA at lysine 310 (K310) by SETD6 creates a binding site for
GLP, which in turn methylates H3K9 at NF-kB target genes to inhibit tran-
scription. Phosphorylation of RelA at serine 311 (S311) by PKCz blocks binding
of GLP to RelA (Levy et al., 2011) and, along with other RelA modifications not
shown, promotes its interaction with CBP, leading to histone acetylation and
activation of NF-kB target genes (Duran et al., 2003).
(B) Phosphorylation of NEMO by ATM in response to a DSB promotes its
export from the nucleus. In the cytoplasm, NEMO activates the IKK complex,
leading to IkB phosphorylation and degradation and NF-kB (RelA-p50)
translocation to the nucleus, where it can activate transcription as shown in (A).
Note that some ATM may translocate with NEMO to the cytoplasm and
participate in IKK activation.genes and can regulate multiple steps during transcription
(Laribee et al., 2007; Mohan et al., 2010; Wyce et al., 2007).
These crosstalk events are conserved, at least in part, in
mammalian systems (Kim et al., 2009; Zhou et al., 2011).
Though H2B ubiquitylation is observed in the bodies of all
actively transcribed genes, knockdown of the mammalian
homolog of Bre1, ring finger protein 20 (RNF20), affects the
expression of only a small subset of genes (Shema et al.,
2008). Interestingly, RNF20 depletion not only led to the repres-
sion of some genes, but also caused the upregulation of others.
Genes negatively regulated by RNF20 and H2B ubiquitylation
include several proto-oncogenes, such as c-MYC and c-FOS,
as well as other positive regulators of cell proliferation. On the
other hand, depletion of RNF20 and reduction in H2B ubiquityla-
tion reduced the expression of the p53 tumor suppressor gene
and impaired the activation of p53 in response to DNA damage.
Consistent with these selective changes in gene expression,
RNF20 depletion elicited a number of phenotypes associated
with oncogenic transformation. The suggestion that RNF20
may function as a tumor suppressor is further supported by
the finding of decreased levels of RNF20 and H3K79methylation
in testicular seminomas (Chernikova et al., 2012) and the obser-
vation that the RNF20 promoter is hypermethylated in some
breast cancers (Shema et al., 2008).
Amore concrete link between these histonemodifications and
human cancer comes from leukemias bearing translocations of
the mixed lineage leukemia (MLL) gene. MLL is a H3K4 methyl-
transferase related to the yeast Set1 protein found in the
COMPASS complex. A number of different gene partners are
found to be translocated to the MLL locus, and this invariably
creates anMLL fusion protein that lacks H3K4methyltransferase
activity. Interestingly, many of the translocation partners are part
of a ‘‘superelongation complex’’ that stimulates progress of the
polymerase through gene bodies (Mohan et al., 2010; Smith
et al., 2011). Data suggest that at least some of these oncogenic
MLL fusion proteins alter the expression of select target genes,
such as HOXA, by increasing H3K79 methylation (Okada et al.,
2005). Knockdown of Dot1 reduced H3K79 methylation at these
targets and inhibited oncogenic transformation by MLL fusion
proteins. These examples demonstrate how deregulation of
crosstalk among different histone modifications can contribute
to diseases such as cancer.
Not Just for Histones
Just as in histones, modifications in nonhistone proteins are
subject to regulatory crosstalk and serve as platforms for binding
of ‘‘reader’’ proteins. For example, a yeast kinetochore protein,
Dam1, is methylated at K233 by the Set1 methyltransferase, an
ortholog of mammalian MLL proteins (Zhang et al., 2005). The
functions of Dam1, like those of other kinetochore proteins, are
highly regulated by Aurora-kinase-mediated phosphorylation
(Lampson and Cheeseman, 2011). At least some of these phos-
phorylation events are inhibited by prior methylation of Dam1,
creating a phosphomethyl switch that impacts chromosome
segregation (Zhang et al., 2005).
Another more complicated example of a phosphomethyl regu-
latory cassette occurs in the RelA subunit of NF-kB (Levy et al.,
2011). RelA is monomethylated by SETD6 at K310, and this686 Cell 152, February 14, 2013 ª2013 Elsevier Inc.modification inhibits RelA functions in transcriptional activation
through recruitment of another methyltransferase, G9a-like
protein (GLP). GLP binds to K310me1 in RelA and induces a
repressive histone modification, H3K9me, in RelA target genes.
Phosphorylation of the adjacent S311 in RelA, however, blocks
GLP association with RelA and instead promotes the recruitment
of CREB-binding protein (CBP) to activate transcription of NF-kB
targets (Duran et al., 2003) (Figure 1A).
These two examples in yeast and in mammalian cells
likely foreshadow the discovery of many additional regulatory
‘‘switches’’ created by modification crosstalk. The p53 tumor
suppressor is a prime candidate for such regulation, as it harbors
several diverse modifications. Moreover, many kinase con-
sensus sites contain arginine or lysine residues, providing a
high potential for phosphomethyl, phosphoacetyl, or phosphou-
biquitin switches (Rust and Thompson, 2011).
The induction of H3K9me by recruitment of GLP via a methyl-
ation event in RelA illustrates how a signaling pathway, in this
case mediated by NF-kB, can transduce a signal to chromatin.
However, signaling can also occur in the other direction; that
is, a histone modification can affect the modification state of
a nonhistone protein.Methylation of Dam1, for example, requires
ubiquitylation of histone H2B (Latham et al., 2011). Most likely,
H2Bub recruits the Set1 complex to centromeric nucleosomes,
positioning it for methylation of Dam1 at the kinetochore. Thus,
transregulation of posttranslational modifications can occur
both between histones (such as H2Bub and H3K4me) and
between histones and nonhistones (such as H2Bub and Dam1-
K233me), providing a platform for bidirectional signaling from
chromatin.
Signaling to and from Chromatin in Response to DNA
Damage
Signaling to and from chromatin impacts other important cellular
processes as well. DNA repair involves coordination among the
repair machinery, chromatin modifications, and cell-cycle
checkpoint signaling. At the apex of the DNA damage response
are three kinases related to the PI3 kinase family, ataxia telangi-
ectasia mutated (ATM), ATM and Rad3-related protein (ATR),
and DNA-PK (Jackson and Bartek, 2009; Lovejoy and Cortez,
2009). DNA-PK is activated when its regulatory subunit Ku70/
80 binds to the end of a DNA double-strand break (DSB). ATR
activation involves recognition of single-stranded DNA coated
with replication protein A (RPA) by the ATR-interacting protein,
ATRIP, as well as direct interaction with topoisomerase IIb-bind-
ing protein (TopBP1) (Burrows and Elledge, 2008). Like DNA-PK,
ATM is also activated in response to DSBs, but rather than
recognition of broken DNA ends, ATM appears to be activated
in response to large-scale changes in chromatin structure
caused by a DSB (Bakkenist and Kastan, 2003). How alterations
in chromatin structure are signaled to ATM is at present unclear.
One of the earliest events in the DNA damage response is the
phosphorylation of a variant of histone H2A, H2AX, by ATM,
DNA-PK, and/or ATR (Rogakou et al., 1998). Phosphorylated
H2AX (gH2AX) provides a mediator of DNA damage signaling
directed by these kinases, and this modification is found in flank-
ing chromatin regions as far as one megabase from a DNA DSB.
This phosphorylation event creates a binding motif for the medi-
ator of DNA damage checkpoint (MDC1) protein, which in turn
recruits other proteins, such as Nijmegen breakage syndrome
1 (NBS1) and RNF8, to sites of DSBs through additional phos-
pho-specific interactions (Chapman and Jackson, 2008; Kolas
et al., 2007; Stucki and Jackson, 2006). NBS1 is part of the
MRN complex that also contains Mre11 and Rad50 and is
involved in DNA end processing for both the homologous recom-
bination and nonhomologous end-joining pathways of DSB
repair (Zha et al., 2009). In addition, NBS1 functions as a cofactor
for ATM by stimulating its kinase activity and recruiting ATM to
sites of DSBs where many of it substrates are located (Lovejoy
and Cortez, 2009; Zha et al., 2009). ATM also phosphorylates
effector proteins that only transiently localize to DSBs. One of
these proteins is the checkpoint 2 (Chk2) kinase, which can be
activated by ATM-mediated phosphorylation at sites of damage
but then spreads throughout the nucleus to phosphorylate and
regulate additional proteins as part of the DNA damage response
(Bekker-Jensen et al., 2006). ATM also phosphorylates tran-
scription factors, such as p53 and E2F1, to regulate the expres-
sion of numerous genes involved in the cellular response to
DSBs (Banin et al., 1998; Biswas and Johnson, 2012; Canman
et al., 1998; Lin et al., 2001). These events again illustrate that
signals to chromatin, in this case resulting in H2AX phosphoryla-
tion, can be relayed to other proteins both on and off of the chro-
matin-DNA template.
Bidirectional signaling is illustrated even further by another
branch of the ATM-mediated DNA damage response that
involves activation of NF-kB. NF-kB is normally sequestered in
an inactive state in the cytoplasm through its association with
IkB. Following ATM activation by a DNA DSB, ATM phosphory-
lates NF-kB essential modulator (NEMO) in the nucleus (Wuet al., 2006), which promotes additional modifications to
NEMO and export from the nucleus to the cytoplasm. Once in
the cytoplasm, NEMOparticipates in the activation of the canon-
ical inhibitor of NF-kB (IkB) kinase (IKK) complex that targets IkB
for degradation, leading to NF-kB activation. NF-kB then trans-
locates to the nucleus, where it regulates the expression of
genes that are important for cell survival following DNA damage.
In this case, a change in chromatin structure caused by a DSB
initiates a signal that travels to the cytoplasm and back to the
nucleus to activate transcription of NF-kB target genes by modi-
fying chromatin structure (Figure 1).
Multiple Roles for H2B Ubiquitylation
In addition to phosphorylation of H2A/H2AX, a number of other
histone modifications are induced at sites of DSBs in yeast
and mammalian cells. One such modification is H2Bub, the
same mark involved in regulating transcription as described
above. As with transcription, the Bre1 ubiquitin ligase (RNF20-
RNF40 in mammalian cells) is responsible for H2Bub at sites of
DNA damage (Game and Chernikova, 2009; Moyal et al., 2011;
Nakamura et al., 2011). Moreover, H2Bub is required for and
promotes H3K4 and H3K79 methylation at sites of damage,
similar to its role at actively transcribed genes. These histone
modifications are important for altering chromatin structure to
allow access to repair factors involved in DNA end resection
and processing (Moyal et al., 2011; Nakamura et al., 2011).
Moreover, H2Bub and H3K79me are not only required for DNA
repair but are also important for activating the Rad53 kinase
and for imposing subsequent cell-cycle checkpoints (Giannat-
tasio et al., 2005). Blocking H2B ubiquitylation or H3K79 methyl-
ation in response to DSBs inhibits Rad53 activation and impairs
the G1 and intra S phase checkpoints.
Bre1-mediated H2B ubiquitylation and subsequent methyla-
tion of H3K4 by Set1 and H3K79 by Dot1 are also involved in
regulating mitotic exit in yeast. The Cdc14 phosphatase controls
mitotic exit by dephosphorylating mitotic cyclins and their
substrates during anaphase (D’Amours and Amon, 2004). Prior
to anaphase, Cdc14 is sequestered on nucleolar chromatin
through interaction with its inhibitor, the Cf1/Net1 protein. Two
pathways, Cdc fourteen early anaphase release (FEAR) and
mitotic exit network (MEN), control the release of Cdc14 from
ribosomal DNA (rDNA) in the nucleolus. Upon inactivation of
the MEN pathway, H2B ubiquitylation and methylation of H3K4
and H3K79 are necessary for FEAR-pathway-mediated release
of Cdc14 from the nucleolus (Hwang and Madhani, 2009). It
appears that alteration of rDNA chromatin structure induced by
these modifications is important for this process.
Thus, depending on its chromosomal location, H2Bub can
regulate gene transcription, DNA repair and checkpoint sig-
naling, mitotic exit, and chromosome segregation (Figure 2).
The ability of this modification to affect methylation of both
histone (H3K4 and H3K79) and nonhistone proteins in trans high-
lights its potential to serve as a nexus of signals coming into and
emanating from chromatin.
Unanswered Questions
The roles of H2B ubiquitylation and H3K4 and H3K79 meth-
ylation in regulating nontranscriptional processes are wellCell 152, February 14, 2013 ª2013 Elsevier Inc. 687
Figure 2. H2Bub Passes Signals to Different Receivers
In yeast, Bre1-mediated ubiquitylation of H2B promotes H3K4 and Dam1
methylation by Set1 and H3K79 methylation by Dot1. Depending on its loca-
tion, H2Bub can participate in the regulation of transcription, chromosome
segregation, cell-cycle checkpoints, and mitotic exit.established in yeast. An unanswered question is whether these
histone modifications regulate similar cellular processes in hu-
mans. If so, then defects in chromatin signaling, independent
of transcription, could contribute to diseases associated with
alterations in histone-modifying enzymes. At present, studies
aimed at understanding the oncogenic properties of MLL fusion
proteins have focused on their abilities to regulate transcription.
Likewise, the putative tumor suppressor function of RNF20 is
assumed to be due to selective regulation of certain genes
(Shema et al., 2008). However, it is possible that defects in the
DNA damage response or chromosomal segregation might
contribute to the oncogenic properties of MLL fusion proteins
or participate in the transformed phenotype associated with
depletion of RNF20. Indeed, RNF20 was recently shown to
localize to sites of DNA DSBs to promote repair and maintain
genome stability, a function that is apparently independent of
transcriptional regulation.
The importance of chromatin organization and reorganization
for the regulation of gene expression and other DNA-templated
processes cannot be argued. Defining how such changes are
triggered by incoming signals is clearly important for under-
standing how cells respond to changes in their environment,
developmental cues, or insults to genomic integrity. However,
emerging studies indicate that chromatin is not simply an
obstacle to gene transcription or DNA repair. Rather, it is an
active participant in these processes that can provide real-time
signals to facilitate, amplify, or terminate cellular responses.
Given the regulatory potential of modification crosstalk within
histones and between histone and nonhistone proteins, coupled
with ongoing definitions of vast networks of protein methylation,
acetylation, and ubiquitylation events, our current view of
signaling pathways as ‘‘one-way streets’’ that dead end at chro-
matin is likely soon to be converted into a view of chromatin
as an information hub that directs multilayered and multidirec-
tional regulatory networks. Defining these networks will not
only provide a greater understanding of biological processes,
but will also provide entirely new game plans for combating688 Cell 152, February 14, 2013 ª2013 Elsevier Inc.complex human diseases that result from inappropriate signal
transduction.
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